Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530177 · ClinicalTrials.gov registry record
Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
A clinical trial of Non-metastatic Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 546
- Enrollment target
- 1
- Study location
NCT02530177: Active study of Non-metastatic Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02530177 is a study of Non-metastatic Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 546 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02530177, a study of Non-metastatic Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 546 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see how many patients develop hair, skin and nail changes due to cancer treatments. The investigators would like to study the clinical factors, genetic markers, and impact on patients' health-related quality of life to learn more about who is at greater risk. We trust that the study will improve our understanding of how cancer patients feel about their skin, hair, and nail conditions. This information will help us determine the burden on breast cancer patients and survivors. It will also help us learn how to prevent these conditions and it may improve the way we treat them and counsel patients.
Primary Outcome
as assessed clinically and by phototrichogram assessments, among women exposed to cytotoxic chemotherapy
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- OTHER Clinical Assessments
- OTHER Saliva sample
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2015-08-19 |
| Est. Completion | 2026-08 |
What the registry record for NCT02530177 still lists
NCT02530177 is an observational study that tracks outcomes without assigning an intervention. The registered 546 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Non-metastatic Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Questionnaires is the first listed.
NCT02530177 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02530177 about?
NCT02530177 is a clinical study titled "Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer". The purpose of this study is to see how many patients develop hair, skin and nail changes due to cancer treatments. The investigators would like to study the clinical factors, genetic markers, and impact on patients' health-related quality of life to learn more about who is at greater risk. We trust...
What is the current status of trial NCT02530177?
This trial is currently active not recruiting. The enrollment target is 546 participants. The study started on 2015-08-19. Estimated completion is 2026-08.
What conditions does trial NCT02530177 study?
This clinical trial studies the following conditions: Non-metastatic Breast Cancer.
What interventions are being tested in trial NCT02530177?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Clinical Assessments (OTHER), Saliva sample (OTHER).
Who is sponsoring clinical trial NCT02530177?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02530177 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI